These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


725 related items for PubMed ID: 30918344

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vitamin C promotes oligodendrocytes generation and remyelination.
    Guo YE, Suo N, Cui X, Yuan Q, Xie X.
    Glia; 2018 Jul; 66(7):1302-1316. PubMed ID: 29423921
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of MAPK/ERK pathway promotes oligodendrocytes generation and recovery of demyelinating diseases.
    Suo N, Guo YE, He B, Gu H, Xie X.
    Glia; 2019 Jul; 67(7):1320-1332. PubMed ID: 30815939
    [Abstract] [Full Text] [Related]

  • 5. The orphan G protein-coupled receptor GPR149 is a negative regulator of myelination and remyelination.
    Suo N, He B, Cui S, Yang Y, Wang M, Yuan Q, Xie X.
    Glia; 2022 Oct; 70(10):1992-2008. PubMed ID: 35758525
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. mTOR Signaling Regulates Metabolic Function in Oligodendrocyte Precursor Cells and Promotes Efficient Brain Remyelination in the Cuprizone Model.
    Jeffries MA, McLane LE, Khandker L, Mather ML, Evangelou AV, Kantak D, Bourne JN, Macklin WB, Wood TL.
    J Neurosci; 2021 Oct 06; 41(40):8321-8337. PubMed ID: 34417330
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Myt1L Promotes Differentiation of Oligodendrocyte Precursor Cells and is Necessary for Remyelination After Lysolecithin-Induced Demyelination.
    Shi Y, Shao Q, Li Z, Gonzalez GA, Lu F, Wang D, Pu Y, Huang A, Zhao C, He C, Cao L.
    Neurosci Bull; 2018 Apr 06; 34(2):247-260. PubMed ID: 29397565
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Teriflunomide Promotes Oligodendroglial 8,9-Unsaturated Sterol Accumulation and CNS Remyelination.
    Martin E, Aigrot MS, Lamari F, Bachelin C, Lubetzki C, Nait Oumesmar B, Zalc B, Stankoff B.
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov 06; 8(6):. PubMed ID: 34642237
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Functional Effects of Cuprizone-Induced Demyelination in the Presence of the mTOR-Inhibitor Rapamycin.
    Yamate-Morgan H, Lauderdale K, Horeczko J, Merchant U, Tiwari-Woodruff SK.
    Neuroscience; 2019 May 15; 406():667-683. PubMed ID: 30703503
    [Abstract] [Full Text] [Related]

  • 19. Engineering biomaterial microenvironments to promote myelination in the central nervous system.
    Unal DB, Caliari SR, Lampe KJ.
    Brain Res Bull; 2019 Oct 15; 152():159-174. PubMed ID: 31306690
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.